ARL 67156 trisodium salt hydrate
SIGMA/A265 - ≥98% (HPLC), solid
Synonym: 6-N,N-Diethyl-β-γ-dibromomethylene-D-adenosine-5′-triphosphate trisodium salt hydrate; FPL 67156
CAS Number: 160928-38-1 (free acid)
Empirical Formula (Hill Notation): C15H21Br2N5Na3O12P3 · xH2O
Molecular Weight: 785.05 (anhydrous basis)
MDL Number: MFCD12910436
Linear Formula: C15H21Br2N5Na3O12P3 · xH2O
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to off-white |
form | solid |
InChI | 1S/C15H24Br2N5O12P3.3Na.H |
InChI key | UWMONIJVKGTUGE-OPKBHZIBSA |
Quality Level | 100 |
SMILES string | O.[Na+].[Na+].[Na+].CCN(C |
solubility | DMSO: insoluble |
H2O: >20 mg/mL | |
storage temp. | −20°C |
Application: | ARL 67156 trisodium salt hydrate has been used: • to prevent ATP degradation during cerebrospinal fluid extraction • as an ATPase inhibitor in ATP quantification assay for preventing ATP degradation in cytoplasm and mitochondrion • as an ecto-ATPase inhibitor to treat cancer cells for ATP release assay |
Biochem/physiol Actions: | ecto-ATPase inhibitor; prevents metabolism of P2 purinoceptor agonists. |
General description: | ARL 67156, a nucleotide/ATP analog is a competitive inhibitor of CD39. This ecto-ATPase inhibitor is presumed to be metabolically stable in biological studies due to its β, γ-dibromomethylene bridge. |
General description: | ARL-67156 preferentially inhibits the degradation of ADP compared to the degradation of ATP in the murine colon. It is commonly employed to inhibit ATP hydrolysis in tissue preparations. |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Purity | ≥98% (HPLC) |
Storage Temp. | −20°C |
UNSPSC | 12352200 |